Search details
1.
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.
Breast Cancer Res Treat
; 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38568368
2.
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer.
Breast Cancer Res
; 24(1): 74, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36320066
3.
The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
Ann Surg Oncol
; 29(12): 7739-7747, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35810223
4.
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
Cancer
; 126(22): 4847-4858, 2020 11 15.
Article
in English
| MEDLINE | ID: mdl-32780421
5.
Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.
J Surg Oncol
; 122(4): 611-618, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32497318
6.
Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score® test.
Breast Cancer Res Treat
; 177(3): 611-618, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31302854
7.
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Breast Cancer Res Treat
; 168(1): 69-77, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29128898
8.
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial).
BMC Cancer
; 18(1): 526, 2018 May 04.
Article
in English
| MEDLINE | ID: mdl-29728098
9.
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
Breast Cancer Res Treat
; 161(1): 17-28, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27785654
10.
ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
Ann Surg Oncol
; 29(12): 7750, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35798896
11.
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
Breast Cancer Res Treat
; 159(1): 71-8, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27447876
12.
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.
Breast Cancer Res
; 17(1): 133, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26429296
13.
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Breast Cancer Res Treat
; 152(2): 389-98, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-26119102
14.
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell
; 10(6): 515-27, 2006 Dec.
Article
in English
| MEDLINE | ID: mdl-17157791
15.
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.
Diagnostics (Basel)
; 14(9)2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38732326
16.
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer.
J Clin Oncol
; 41(20): 3565-3575, 2023 Jul 10.
Article
in English
| MEDLINE | ID: mdl-37406456
17.
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.
JCO Precis Oncol
; 7: e2200543, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37027813
18.
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Breast Cancer Res Treat
; 134(2): 683-92, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22547108
19.
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.
Breast Cancer Res Treat
; 135(3): 913-22, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22941572
20.
The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.
Ann Surg Oncol
; 19(3): 1034-42, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-21989664